These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 33763655)
1. Toward a broader view of mechanisms of drug cardiotoxicity. Mamoshina P; Rodriguez B; Bueno-Orovio A Cell Rep Med; 2021 Mar; 2(3):100216. PubMed ID: 33763655 [TBL] [Abstract][Full Text] [Related]
2. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities. Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047 [TBL] [Abstract][Full Text] [Related]
3. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress. Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273 [TBL] [Abstract][Full Text] [Related]
4. Methylene Blue Counteracts H Cheung JY; Wang J; Zhang XQ; Song J; Davidyock JM; Prado FJ; Shanmughapriya S; Worth AM; Madesh M; Judenherc-Haouzi A; Haouzi P Cardiovasc Toxicol; 2018 Oct; 18(5):407-419. PubMed ID: 29603116 [TBL] [Abstract][Full Text] [Related]
5. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity. Yang X; Papoian T J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688 [TBL] [Abstract][Full Text] [Related]
7. Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies. Kim CW; Choi KC Life Sci; 2021 Jul; 277():119607. PubMed ID: 33992675 [TBL] [Abstract][Full Text] [Related]
8. Clinical Trial in a Dish: Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity. Lam CK; Wu JC Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):1019-1031. PubMed ID: 33472401 [TBL] [Abstract][Full Text] [Related]
9. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Koleini N; Kardami E Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146 [TBL] [Abstract][Full Text] [Related]
10. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity. Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress. Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254 [TBL] [Abstract][Full Text] [Related]
12. Continued exposure of anti-cancer drugs to human iPS cell-derived cardiomyocytes can unmask their cardiotoxic effects. Sakamoto K; Sakatoku K; Sugimoto S; Iwasaki N; Sano Y; Yamaguchi M; Kurokawa J J Pharmacol Sci; 2019 Aug; 140(4):345-349. PubMed ID: 31521491 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936 [TBL] [Abstract][Full Text] [Related]
14. Ocular toxicity from systemic drug therapy. An overview of clinically important adverse reactions. Davidson SI; Rennie IG Med Toxicol; 1986; 1(3):217-24. PubMed ID: 3784843 [No Abstract] [Full Text] [Related]
15. Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity. Boran T; Akyildiz AG; Jannuzzi AT; Alpertunga B Toxicol Lett; 2021 Jan; 336():39-49. PubMed ID: 33166663 [TBL] [Abstract][Full Text] [Related]
16. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. Anjos M; Fontes-Oliveira M; Costa VM; Santos M; Ferreira R Life Sci; 2021 Sep; 280():119760. PubMed ID: 34166713 [TBL] [Abstract][Full Text] [Related]
17. Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association. Gintant G; Burridge P; Gepstein L; Harding S; Herron T; Hong C; Jalife J; Wu JC Circ Res; 2019 Oct; 125(10):e75-e92. PubMed ID: 31533542 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced mitochondrial dysfunction and cardiotoxicity. Varga ZV; Ferdinandy P; Liaudet L; Pacher P Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1453-67. PubMed ID: 26386112 [TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs. Sachinidis A Cells; 2020 Apr; 9(4):. PubMed ID: 32316481 [TBL] [Abstract][Full Text] [Related]
20. Chronic cardiotoxicity assessment of BMS-986094, a guanosine nucleotide analogue, using human iPS cell-derived cardiomyocytes. Yanagida S; Satsuka A; Hayashi S; Ono A; Kanda Y J Toxicol Sci; 2021; 46(8):359-369. PubMed ID: 34334557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]